Akorn Inc. (AKRX) Profile

Profile for Akorn Inc. (AKRX)

After Hours: $ 12.151

-0.329 (-2.64%)

Volume: 20.1 k

4:02 PM EST Feb 10, 2012


Business Description: Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others.

Address:	1925 W. Field Court, Suite 300, Lake forest, IL, 60045
Telephone:	(847) 279-6100	Website:	www.akorn.com
Facsimile:	N/A	Email:	investor.relations@akorn.com


Details

CEO:	Rajat Rai
Employees:	410	Market Cap:	1.18 b
Issue Type:	CS
Auditor:	Ernst & Young LLP
Last Audit:	Unqualified
Indices:	Drugs - Generic


Industry Classifications

Sector:	Healthcare	CIK:	0000003116
Industry:	Drugs
Sub-Industry:	Drugs - Generic
NAICS:	Pharmaceutical Preparation Manufacturing (325412)
SIC:	Pharmaceutical Preparations (2834)

Tags for Akorn Inc.

Research stocks or mutual funds related to Akorn Inc. by keywords or tags. Find companies that have a similar focus to AKRX. The keywords below have been associated to AKRX by either user submission or electronic means.

pharmaceutical intermediate pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceutical research and development biotech jobs pharmaceutical manufacturing company pharma marketing lysine ointment pharmaceutical software pharma manufacturing gmp labeling kv pharmaceutical company generic products pharmaceutical ingredients active pharmaceutical ingredient pharmaceutical cro pharma companies active pharmaceutical ingredients pharmaceutical sales pharmaceutical conferences pharma pharmaceutical distributors pharmaceutical solution pharmaceutical development pharmaceutical sales rep pharmaceutical reports fda manufacturer pharmaceutical production pharmaceutical magazine pharmaceutical consultant biotech pharmaceutical product labeling Drugs pharmaceutical dextran pharmaceutical industry news pharmaceutical capsules pharmaceutical manufacturing software pharmaceutical conference pharmaceutical manufacturing pharmaceutical formulation specialty pharmaceuticals dextran usp contract manufacturing contract pharmaceutical pharmaceutical consulting pharmaceutical industry veterinary pharmaceutical pharmaceutical advances pharmaceutical distributor

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.